milrinone has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Excerpt | Relevance | Reference |
---|---|---|
"Levosimendan was more efficient than milrinone for treating the hemodynamic manifestations of the postcardiopulmonary bypass low-output syndrome." | 2.72 | Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. ( Al-Shawaf, E; Ayed, A; Dehrab, N; Radomir, B; Tarazi, R; Vislocky, I, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Shawaf, E | 1 |
Ayed, A | 1 |
Vislocky, I | 1 |
Radomir, B | 1 |
Dehrab, N | 1 |
Tarazi, R | 1 |
1 trial available for milrinone and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery.
Topics: Adult; Aged; Blood Pressure; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Di | 2006 |